CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024

About this update from Canadabis Capital, Inc.

[{"type":"text","content":"\n \n \n \n CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Enhanced Operational Efficiency and Strategic Investments Drive Continued Profitability\n \n \n \n \n \n \n CALGARY, AB\n \n \n ,\n \n \n June 26, 2024\n \n \n /CNW/ - CanadaBis Capital Inc. (the \"Company\" or \"CanadaBis\") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis (\"MD&A\") are filed on SEDAR at\n \n www.sedarplus.ca\n \n . This quarter reflects another period generating positive earnings and Adjusted EBITDA1 for CanadaBis, The Company has allocated capital to innovation designed to remain ahead of competitors and to expand the SKU offering by adding multiple new products for future release. To support the Company's product enhancement initiatives, we have continued to adjusted our strategy to increase brand awareness and capture market share through an extensive nation-wide campaign designed to equip retailers with enhanced awareness of the various SKUs, programs and educational value-adds to CanadaBis' wide variety of high-quality, lower-cost products. While such investments can have an impact on results in the immediate quarters, reinvesting in the business is critical to support the Company's top and bottom line over the longer- term.\n \n \n \n \n \n \n \n \n \n Stigma Grow continues to re-formulate concentrate and pre roll lines to meet demands from current clients to maintain larger terpene and cannabinoid profiles across the product offerings while also earning repeat sales. With these ongoing improvements, coupled with demand for our award-winning Infused Pre-rolls, Electric Dartz, Live Rosin Vapes and High-CBD Cartridges, CanadaBis anticipates continued positive performance in remainder of Fiscal 2...

More updates from Canadabis Capital, Inc.